Zibb.com: Accelrys, Incorporated (Industry News & Blogs)

Accelrys Inc. Announces Blog for Scientific and Engineering Resea...

Fri, 21 Aug 2009 12:00:00 GMT

SAN DIEGO, CA, August 21, 2009 Accelrys, Inc. (NASDAQ: ACCL), a leading provider of scientific business intelligence software and services, is pleased to announce their blog for the scientific and engineering research community at http://blog.accelrys.com/.Accelrys recently made its

Pfizer Inaugural Member of Accelrys Enterprise Cheminformatics Co...

Fri, 02 Feb 2007 00:00:00 GMT

Accelrys added Pfizer to the Accelrys Enterprise Cheminformatics Consortium. This Consortium is a collaborative software development project led by Accelrys. The goal is

Accelrys Now Supports Microsoft Office SharePoint

Accelrys, Inc. now supports Microsoft Office SharePoint Server 2007 as a publication platform for Accelrys' scientific applications.

Press Releases: Pharmacopeia

Bristol-Myers Squibb Company initiated Phase I clinical trials in Canada with a novel small molecule drug candidate resulting from the collaboration between the two companies.

CLC bio: CLC bio partners with Accelrys

We are happy to announce our collaboration with Accelrys, who develops and commercializes scientific business intelligence software for the integration, mining, analysis, modeling and simulation, management and interactive reporting of scientific data.

PharmiWeb: The Heart of Life Sciences on the Web

Countries covered: Global Although much of medicine is focused on the increased aging of the population, children still represent the bulk the dependent population worldwide. Important regulatory factors are at work in the pediatric pharmaceutical market.

Dr. Frank Brown of Accelrys Inc. Named to Board of Directors of B...

Tue, 18 Aug 2009 12:00:00 GMT

SAN DIEGO, CA--(Marketwire - August 18, 2009) - Highlighted LinksAccelrysBioIT Alliance<...

Accelrys Inc. Releases New Modeling and Simulation Software for L...

Mon, 29 Jun 2009 12:00:00 GMT

SAN DIEGO, CA--(Marketwire - June 29, 2009) - Highlighted LinksAccelrysDiscovery Studio...

Accelrys Inc. Leads Consortium That Receives Best Practices Award...

Wed, 06 May 2009 12:00:00 GMT

SAN DIEGO, CA--(Marketwire - May 05, 2009) - Highlighted LinksAccelrys Accelrys, Inc. (NASDAQ: ACCL), a leading...

Dr. Frank Brown of Accelrys Inc. to Present at Nanotech Conferenc...

Thu, 30 Apr 2009 12:00:00 GMT

SAN DIEGO, CA--(Marketwire - April 29, 2009) - Highlighted LinksAccelrysNanotech 2009...

Accelrys Inc. Receives Growth Strategy Leadership Award From for ...

Mon, 20 Apr 2009 12:00:00 GMT

SAN DIEGO, CA--(Marketwire - April 20, 2009) - Highlighted LinksAcclerysFrost & Sullivan<...

Accelrys Inc. Announces Resignation of Chief Executive Officer an...

Wed, 07 Jan 2009 12:00:00 GMT

SAN DIEGO--(BUSINESS WIRE)--Accelrys, Inc. (NASDAQ: ACCL - News) today reported that Mark Emkjer, its President and Chief Executive Officer has resigned as an officer and director of the company, effective January 5, 2009. Mr. Emkjer will remain employed by the Company until February 1, 2009 to

Accelrys Inc. Releases Cheminformatics Collection for Pipeline Pi...

Tue, 14 Apr 2009 12:00:00 GMT

SAN DIEGO, CA--(Marketwire - April 14, 2009) - Highlighted LinksAccelrys Accelrys, Inc. (NASDAQ: ACCL), a leading...

Press Releases: Pharmacopeia

Pharmacopeia, Inc. (Nasdaq: ACCL) and Pharmacopeia Drug Discovery, Inc. (Nasdaq: PCOP) ( PDD ) today announced the completion of the spin-off of PDD, Pharmacopeia s drug discovery business, into an independent, separately traded, publicly held company.

Press Releases: Pharmacopeia

Pharmacopeia, Inc. (Nasdaq:ACCL) and Pharmacopeia Drug Discovery, Inc. (Nasdaq:PCOP) today announced consolidated results for the quarter ended March 31, 2004.